DE10192165D2 - Needy for the treatment of immune reactions in the eye - Google Patents

Needy for the treatment of immune reactions in the eye

Info

Publication number
DE10192165D2
DE10192165D2 DE10192165T DE10192165T DE10192165D2 DE 10192165 D2 DE10192165 D2 DE 10192165D2 DE 10192165 T DE10192165 T DE 10192165T DE 10192165 T DE10192165 T DE 10192165T DE 10192165 D2 DE10192165 D2 DE 10192165D2
Authority
DE
Germany
Prior art keywords
needy
eye
treatment
immune reactions
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE10192165T
Other languages
German (de)
Inventor
Friedrich Hoffmann
Merediz Sven Andreas Koenig
Burghardt Wittig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOLOGEN FORSCHUNGS ENTWICKLUNG
Original Assignee
MOLOGEN FORSCHUNGS ENTWICKLUNG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOLOGEN FORSCHUNGS ENTWICKLUNG filed Critical MOLOGEN FORSCHUNGS ENTWICKLUNG
Priority to DE10192165T priority Critical patent/DE10192165D2/en
Application granted granted Critical
Publication of DE10192165D2 publication Critical patent/DE10192165D2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
DE10192165T 2000-05-27 2001-05-27 Needy for the treatment of immune reactions in the eye Ceased DE10192165D2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE10192165T DE10192165D2 (en) 2000-05-27 2001-05-27 Needy for the treatment of immune reactions in the eye

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10025920A DE10025920A1 (en) 2000-05-27 2000-05-27 Methods and agents for treating immune reactions in the eye
DE10192165T DE10192165D2 (en) 2000-05-27 2001-05-27 Needy for the treatment of immune reactions in the eye
PCT/DE2001/002081 WO2001091799A2 (en) 2000-05-27 2001-05-27 Medicament for the treatment of immune reactions in the eye

Publications (1)

Publication Number Publication Date
DE10192165D2 true DE10192165D2 (en) 2002-08-29

Family

ID=7643528

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10025920A Withdrawn DE10025920A1 (en) 2000-05-27 2000-05-27 Methods and agents for treating immune reactions in the eye
DE10192165T Ceased DE10192165D2 (en) 2000-05-27 2001-05-27 Needy for the treatment of immune reactions in the eye

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10025920A Withdrawn DE10025920A1 (en) 2000-05-27 2000-05-27 Methods and agents for treating immune reactions in the eye

Country Status (3)

Country Link
AU (1) AU7046201A (en)
DE (2) DE10025920A1 (en)
WO (1) WO2001091799A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces
WO1995034202A1 (en) * 1994-06-15 1995-12-21 Alexion Pharmaceuticals, Inc. Methods for reducing hyperacute rejection of xenografts
DE19648625A1 (en) * 1996-11-13 1998-05-14 Soft Gene Gmbh Microprojectile for the introduction of substances into cells by ballistic transfer

Also Published As

Publication number Publication date
AU7046201A (en) 2001-12-11
WO2001091799A3 (en) 2002-08-01
WO2001091799A2 (en) 2001-12-06
DE10025920A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
DE69903543D1 (en) FORMULATIONS FOR THE TREATMENT OF REFLUX GENTLE EYES
DE60045386D1 (en) DEVICE FOR THE THERMAL TREATMENT OF BELTS
DE60124302D1 (en) THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES
ATE472325T1 (en) INTRACORPORAL MEDICATIONS FOR THE PHOTODYNAMIC TREATMENT OF DISEASES
ATE265860T1 (en) VACCINE FOR THE TREATMENT OF ATHEROSCLEROSIS
DE60138129D1 (en) APPARATUS FOR THE TREATMENT OF TEETH
DE60019556D1 (en) 2-AMINO-BENZOXAZINE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
ATE417602T1 (en) AGENTS FOR THE TREATMENT OF DISEASES OF THE ESOPHAUS
DE60022916D1 (en) Reboxetine for the treatment of peripheral neuropathies
ATE447947T1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULINRESIENCE
DE60114808D1 (en) SURFACE TREATMENT OF MEDICAL DEVICE
DE60232104D1 (en) Nutritional supplement for the treatment of macular degeneration
DE60113496D1 (en) Use of glycyrrhizin for the treatment of mastitis.
DE60234760D1 (en) PHENYLINDOLE FOR THE TREATMENT OF HIV
DE60019555D1 (en) 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
DE60136477D1 (en) RETINOIDES FOR THE TREATMENT OF EMPHYSEM
ATE384522T1 (en) MEDICATIONS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
DE60123238D1 (en) COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE60204466D1 (en) INTEGRINMA TREATMENT FOR THE TREATMENT OF EYE DISEASES
DE60012138D1 (en) FIBRILLATION TREATMENT DEVICE
DE50013843D1 (en) MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
DE50105735D1 (en) CHLOROZAZAZONE FOR THE TREATMENT OF PSORIASIS
ATE299371T1 (en) ANTICONVULSIVES FOR THE TREATMENT OF AUTISM
DE60006412D1 (en) OXAZINOCHINOLONE FOR THE TREATMENT OF VIRAL INFECTIONS
DE60103685D1 (en) Treatment of poriomania

Legal Events

Date Code Title Description
8131 Rejection